121 related articles for article (PubMed ID: 8935750)
1. Carcino-embryonic antigen--no help with the differential diagnosis.
Cobben-Beld EG; Nortier JW; Kramer WL; van de Wiel A; Rodenburg CJ
Neth J Med; 1996 Mar; 48(3):96-9. PubMed ID: 8935750
[TBL] [Abstract][Full Text] [Related]
2. [Increased blood CEA level as initial manifestation of medullary thyroid carcinoma].
Behr TM; Becker W
Dtsch Med Wochenschr; 1999 Mar; 124(10):303-4. PubMed ID: 10191829
[No Abstract] [Full Text] [Related]
3. Medullary thyroid carcinoma presenting with an initial CEA elevation.
Abraham D; Delbridge L; Clifton-Bligh R; Clifton-Bligh P; Grodski S; Robinson BG; Messina M; Sidhu S
ANZ J Surg; 2010 Nov; 80(11):831-3. PubMed ID: 20969693
[TBL] [Abstract][Full Text] [Related]
4. Rising carcinoembryonic antigen during follow-up for colonic carcinoma--an unusual presentation of medullary carcinoma of the thyroid.
Breeze J; McKinna F; Howlett DC
Clin Oncol (R Coll Radiol); 2008 Jun; 20(5):382. PubMed ID: 18374551
[No Abstract] [Full Text] [Related]
5. [Usefulness of serum calcitonin, CEA and AFP assays in the early detection of medullary thyroid carcinoma relapse].
Łacka K; Michałek K; Majewski P
Wiad Lek; 2002; 55(7-8):394-403. PubMed ID: 12428567
[TBL] [Abstract][Full Text] [Related]
6. Serum calcitonin-negative medullary thyroid carcinoma: role of CgA and CEA as complementary markers.
Giovanella L; Crippa S; Cariani L
Int J Biol Markers; 2008; 23(2):129-31. PubMed ID: 18629788
[TBL] [Abstract][Full Text] [Related]
7. Demonstration and diagnostic significance of pro-gastrin-releasing peptide in medullary thyroid carcinoma.
Inaji H; Komoike Y; Motomura K; Higashiyama M; Ohtsuru M; Funai H; Kasugai T; Koyama H
Oncology; 2000 Aug; 59(2):122-5. PubMed ID: 10971170
[TBL] [Abstract][Full Text] [Related]
8. [The routine immunohistochemical diagnosis and surgical treatment of medullary carcinoma of the thyroid].
Gavrailov M; Petkov R; Mladenov B; Todorov G; Kŭtev N
Khirurgiia (Sofiia); 1995; 48(2):17-9. PubMed ID: 8531439
[TBL] [Abstract][Full Text] [Related]
9. Circulating calcitonin and carcinoembryonic antigen m-RNA detected by RT-PCR as tumour markers in medullary thyroid carcinoma.
Bojunga J; Dragan C; Schumm-Draeger PM; Usadel KH; Kusterer K
Br J Cancer; 2001 Nov; 85(10):1546-50. PubMed ID: 11720443
[TBL] [Abstract][Full Text] [Related]
10. Chronic diarrhea: The first symptom of a metastatic medullary thyroid carcinoma.
Ernaga Lorea A; Migueliz Bermejo I; Eguílaz Esparza N; Hernández Morhain MC; Pineda Arribas J
Gastroenterol Hepatol; 2018 Feb; 41(2):105-107. PubMed ID: 28259364
[No Abstract] [Full Text] [Related]
11. Should serum calcitonin be measured routinely in all patients with nodular thyroid disease?
Sheppard MC
Clin Endocrinol (Oxf); 1995 May; 42(5):451-2. PubMed ID: 7621561
[No Abstract] [Full Text] [Related]
12. [Familial medullary carcinoma of the thyroid. The usefulness of ultrasonography and Doppler color].
Fernández García P; Cervera Deval J; Marco Doménech SF; Laguna Sastre M
Rev Clin Esp; 1998 Nov; 198(11):745-8. PubMed ID: 9883048
[TBL] [Abstract][Full Text] [Related]
13. [High carcinoembryonic antigen level following cancer surgery: another way to detect thyroid medullary carcinoma].
Martinez M; Virally ML; Guillausseau-Scholer C; Vincenot M; Samuel-Lajeunesse J; Mauvais-Jarvis F; Kévorkian JP; Porokhov B; Valleur P; Guillausseau PJ
Rev Med Interne; 2000 Oct; 21(10):897-900. PubMed ID: 11075399
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of sporadic medullary thyroid carcinoma: the importance of routine measurement of serum calcitonin in the diagnostic evaluation of thyroid nodules.
Rieu M; Lame MC; Richard A; Lissak B; Sambort B; Vuong-Ngoc P; Berrod JL; Fombeur JP
Clin Endocrinol (Oxf); 1995 May; 42(5):453-60. PubMed ID: 7621562
[TBL] [Abstract][Full Text] [Related]
15. Persistent elevation of carcinoembryonic antigen as first presentation of a medullary thyroid carcinoma.
Martins A; Gonçalves A; Almeida T; Midões A
BMJ Case Rep; 2018 Jun; 2018():. PubMed ID: 29895542
[TBL] [Abstract][Full Text] [Related]
16. Medullary thyroid carcinoma without marked elevation of calcitonin: a diagnostic and surveillance dilemma.
Wang TS; Ocal IT; Sosa JA; Cox H; Roman S
Thyroid; 2008 Aug; 18(8):889-94. PubMed ID: 18651827
[TBL] [Abstract][Full Text] [Related]
17. [Role of markers in the diagnosis and follow-up of thyroid carcinomas].
Carmignani F; Piscopello L; Sammartini C
Chir Ital; 1994; 46(4):42-5. PubMed ID: 7882442
[TBL] [Abstract][Full Text] [Related]
18. Lack of elevated serum carcinoembryonic antigen and calcitonin in medullary thyroid carcinoma.
Diez JJ; Iglesias P
Thyroid; 2004 Nov; 14(11):984-5. PubMed ID: 15678599
[No Abstract] [Full Text] [Related]
19. [MEN2A incidentally detected by high level of CEA and family history].
Kodama H; To I; Ishiwata J; Shinohara Y; Katayanagi N; Kubota K; Murakami T; Kuroi K; Hayashi K; Toi M
Nihon Naika Gakkai Zasshi; 2001 Apr; 90(4):683-6. PubMed ID: 11391917
[No Abstract] [Full Text] [Related]
20. Abnormal carcinoembryonic antigen levels and medullary thyroid cancer progression: a multivariate analysis.
Machens A; Ukkat J; Hauptmann S; Dralle H
Arch Surg; 2007 Mar; 142(3):289-93; discussion 294. PubMed ID: 17372055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
